QA: OCULAR THERAPEUTIX INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001393434_2023_OCULAR_THERAPEUTIX_INC.pdf

Logs

Graph

Absolute values for 0001393434, OCULAR THERAPEUTIX INC

  xvar xval
0 AssetsCurrent 129,627,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 9,856,000
3 remainder_Assets 9,806,000
4 LiabilitiesCurrent 31,395,000
5 LiabilitiesNoncurrent 22,158,000
6 remainder_Liabilities 60,357,000
7 CostOfGoodsAndServicesSold 4,540,000
8 SellingGeneralAndAdministrativeExpense 32,224,000
9 ResearchAndDevelopmentExpense 53,462,000
10 remainder_Expenses 39,922,000
11 remainder_Revenues 51,494,000
12 remainder_NetIncome 7,616,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 149,289,000
1 Liabilities 113,910,000
2 Expenses 130,148,000
3 Revenues 51,494,000
4 StockholdersEquity 35,379,000
5 NetIncome -71,038,000
6 ComprehensiveNetIncome -71,038,000
7 BaseVar 226,228,500
8 EconomicCapitalRatio -0.0774

Edgar->Model Mapping

Feature Distribution

Change over Time